Assignee
KASHIV BIOSCIENCES LLC
US21 patents
Top patents by PatentIndex Score
US10869839B2Dec 22, 2020
Extended release compositions comprising trihexyphenidyl
KASHIV BIOSCIENCES LLC5 citations84
US10898430B2Jan 26, 2021
Self-regulating osmotic gastroretentive drug delivery systems
KASHIV BIOSCIENCES LLC5 citations83
US10898431B2Jan 26, 2021
Programmable pharmaceutical compositions for chrono drug release
KASHIV BIOSCIENCES LLC8 citations83
US10849846B2Dec 1, 2020
Self-regulating osmotic gastroretentive drug delivery systems
KASHIV BIOSCIENCES LLC6 citations83
US10744083B2Aug 18, 2020
Self-regulating osmotic gastroretentive drug delivery systems
KASHIV BIOSCIENCES LLC6 citations83
US11229606B2Jan 25, 2022
Extended release compositions comprising pyridostigmine
KASHIV BIOSCIENCES LLC1 citations73
US10987311B2Apr 27, 2021
Extended release compositions comprising pyridostigmine
KASHIV BIOSCIENCES LLC2 citations73
US10744093B2Aug 18, 2020
Extended release compositions comprising pyridostigmine
KASHIV BIOSCIENCES LLC2 citations73
US10588863B2Mar 17, 2020
Extended release compositions comprising pyridostigmine
KASHIV BIOSCIENCES LLC2 citations73
US10406234B2Sep 10, 2019
Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms
KASHIV BIOSCIENCES LLC2 citations73
US10857098B2Dec 8, 2020
Gastroretentive dosage forms for sustained drug delivery
KASHIV BIOSCIENCES LLC1 citations71
US10500282B2Dec 10, 2019
Supersaturated stabilized nanoparticles for poorly soluble drugs
KASHIV BIOSCIENCES LLC2 citations71
US12139510B2Nov 12, 2024
Process of purification of protein
KASHIV BIOSCIENCES LLC3 citations66
US12435106B2Oct 7, 2025
Process of purification of protein
KASHIV BIOSCIENCES LLC0 citations53
US12378282B2Aug 5, 2025
Process of purification of protein
KASHIV BIOSCIENCES LLC0 citations53
US12440534B2Oct 14, 2025
Stable ready to dilute composition of carfilzomib
KASHIV BIOSCIENCES LLC0 citations51
US12352759B2Jul 8, 2025
Assay method of antibody
KASHIV BIOSCIENCES LLC0 citations42
US10744131B2Aug 18, 2020
Abuse-resistant drug formulations
KASHIV BIOSCIENCES LLC0 citations40
US10632113B2Apr 28, 2020
Abuse-resistant drug formulations with built-in overdose protection
KASHIV BIOSCIENCES LLC0 citations40
US11760741B2Sep 19, 2023
Pro-drugs of eliglustat
KASHIV BIOSCIENCES LLC0 citations36
US11285152B2Mar 29, 2022
Stable oral pharmaceutical composition of imatinib
KASHIV BIOSCIENCES LLC0 citations36